Stock screener

XENE

Conviction 77HealthcareScan · Mon, Aug 10, 2026
Bullish marubozu
XENE$64.25+1.40%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 561.21K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Xenon Pharmaceuticals Inc.PHARMACEUTICAL PREPARATIONSwww.xenon-pharma.com ↗
Price64.25
Change+1.40%
Gap-0.43%
Rel volume0.40×
Avg volume702.72K
Avg $ vol46.07M
SMA 2065.17
SMA 5060.34
SMA 20050.79
Price vs 50+6.48%
Price vs 200+26.51%
MA stackbullish
50/200 cross—
Supertrenddown · 69.11
RSI (14)53
MACD hist-0.49
MACD cross—
Stoch %K / %D53 / 45
ADX (14)26
+DI / −DI22 / 19
RSI divergence—
MACD divergence—
ATR %+3.31%
ADR %3.07%
52w high70.96
52w low33.43
From 52w high-9.46%
Above 52w low+92.19%
New 52w highNo
SqueezeOff
Bollinger width10.19%
%B0.36
Donchian pos36.70%
Donchian high69.58
Donchian low61.16
AVWAP (52w high)66.66
vs AVWAP high-3.61%
AVWAP (52w low)50.72
vs AVWAP low+26.68%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d0.40×
Avg vol (14d)561.21K
Avg vol (20d)702.72K
Avg $ vol (20d)46.07M
Market cap6.22B
RS 3m (vs SPY)+7.45%
RS 6m (vs SPY)+42.76%
RS line new highNo
Trend template8/8
Technical rank73.0
1 week+3.20%
1 month-6.78%
3 months+13.84%
6 months+55.27%
1 year+91.05%
YTD+44.41%
P/E-17.99
P/B5.01
P/S—
P/FCF-22.23
EPS-4.36
Div yield—
ROE-27.84%
ROA-26.70%
Debt/Eq0.01
Current21.02
EV/EBITDA-16.43
Gross margin—
Net margin—
Rev growth—
EPS growth-47.62%
Price target78.00
Target upside21.40%
Analyst ratingBuy
Institutional107.26%
Ent. value6.12B
Revenue264K
Net income-110.74M
Gross profit—
Free cash flow-279.92M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out96.67M
Employees370
ListedWed, Nov 5, 2014
Free float68.69M
Float %88.9%
Short interest6.34M
Days to cover3.6d
Short volume74.2%
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.11 vs −$1.16
Last surprise+4.3% beat
Setup gradeA
Conviction77 / 100
Pattern quality—
Tech rank73.0 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish marubozu
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Broke out
    Jul 10
    1 scan
  2. Breaking out now
    Aug 5
    1 scan
  3. Broke out
    Aug 6
    1 scan

Congress activity

Disclosed STOCK Act trades in XENE

All disclosures →
No recent disclosed trades by Congress in XENE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XENE · 7 buys · 2 sells

InsiderSideShares
PATOU GARY
Director · Common Shares · 2026-06-05
Other—
Cannon Gillian
Director · Common Shares · 2026-06-05
Sell1.19K
PATOU GARY
Director · Common Shares · 2026-06-05
Sell1.32K
GAROFALO ELIZABETH A.
Director · Share Option (Right to Buy) · 2026-06-03
Grant10.51K
Svoronos Dawn
Director · Restricted Share Units · 2026-06-03
Grant1.59K
PATOU GARY
Director · Share Option (Right to Buy) · 2026-06-03
Grant10.51K
Cannon Gillian
Director · Share Option (Right to Buy) · 2026-06-03
Grant10.51K
Cannon Gillian
Director · Restricted Share Units · 2026-06-03
Grant1.59K
GANNON STEVEN
Director · Restricted Share Units · 2026-06-03
Grant1.59K
Machado Patrick
Director · Share Option (Right to Buy) · 2026-06-03
Grant10.51K

SEC filings

EDGAR filings in XENE · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.